Arbutus Biopharma Corp. (ABUS)

4.43 -0.03 (-0.67%) USD  |  NASDAQ  |  Apr 07, 14:53
More

Arbutus Biopharma Total Capital Stock (3 Year Growth)

Total Capital Stock (3 Year Growth) Chart

View Total Capital Stock (3 Year Growth) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Capital Stock (3 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Capital Stock Definition

View Capital Stock Definition
Start Trial

In economics, capital stock is the plant, equipment, and other assets that help with production.

Read full definition.

Total Capital Stock (3 Year Growth) Range, Past 5 Years

View Total Capital Stock (3 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Capital Stock (3 Year Growth) Benchmarks

View Total Capital Stock (3 Year Growth) Benchmarks
Start Trial
Moderna, Inc. --
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade